Flow Cytometric Analysis of Ploidy in Colorectal Cancer
Author Information
Author(s): R. Silvestrini, I. D'Agnano, A. Faranda, A. Costal, G. Zupi, M. Cosimelli, V. Quagliuolo, D. Giannarelli, L. Gennari, R. Cavaliere
Primary Institution: Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan; Istituto Regina Elena, Rome, Italy
Hypothesis
The study aims to compare the results of flow cytometric analysis of DNA ploidy in colorectal cancer between two Italian cancer research centers.
Conclusion
DNA ploidy was found to be a weak prognostic indicator at 3 years but not at 4 years, with multiploidy indicating worse survival outcomes.
Supporting Evidence
- 63% of tumors were aneuploid in the IRE series and 66% in the INT series.
- Multiploidy was present in 17% of the IRE series and 12% of the INT series.
- Aneuploid tumors in Dukes' stage D were more frequent than in stage A.
- DNA ploidy was a weak prognostic indicator at 3 years but not at 4 years.
- Patients with multiploid tumors had worse relapse-free and overall survival.
Takeaway
Doctors looked at cancer cells to see how many copies of DNA they had, and found that having too many copies can mean a person might not do as well.
Methodology
Fresh and frozen tumor samples were analyzed for DNA ploidy using flow cytometry, comparing results from two cancer institutes.
Limitations
The study's findings may not apply to all colorectal cancer patients due to biological heterogeneity.
Participant Demographics
Patients were from two Italian cancer research centers, with a mix of males and females, and various Dukes' stages.
Statistical Information
P-Value
0.008
Confidence Interval
(1.34-7.27)
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website